Lipidomics and metabolomics as potential biomarkers for breast cancer progression

This review highlights the potential of lipidomic and metabolomic biomarkers in predicting breast cancer prognosis and therapy response, enhancing patient care.

Illumina board agrees to spin off Grail rather than sell the cancer diagnostics firm

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 4, 2024

Older men’s connections often wither when they’re on their own

At age 66, South Carolina physician Paul Rousseau decided to retire after tending for decades to the suffering of people who were seriously ill or

October 10, 2024

CHMP recommends against Mirati’s KRAS rival, in favor of Pfizer’s RSV vaccine, other drugs

The European Medicines Agency’s human medicines committee (CHMP) recommended against conditional authorization for Mirati’s KRAS G12C inhibitor Krazati in non-small cell lung cancer this week,

July 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.